3D Eye Imaging Technology Makes its Debut

United Kingdom-based eye hospital Centre for Sight has introduced a 3D eye imaging system that potentially could transform eye care, telemedicine, and clinical workflows. For the first time, high-definition, fully three-dimensional eye images can now be captured, reviewed and shared remotely—live or retrospectively—on smartphones, tablets, and computers, anywhere in the world.

IMVIS (Infinite Medical Ventures Imaging System) digitizes the traditional slit lamp exam, a core part of eye examinations that has barely changed in more than a century. 

The system is ready for artificial intelligence (AI) machine learning, creating structured, objective datasets that will power future diagnostic algorithms and smart decision-support tools. IMVIS lays the groundwork for AI-driven healthcare in ophthalmology and is set to slash waiting lists, reduce clinician workload, and improve national and global access to specialist care.

Developed by Centre for Sight Medical Director Sheraz Daya and retinal surgeon Professor Tom Williamson, IMVIS is now in use at Centre for Sight’s East Grinstead and Oxshott centers, with London installations coming soon at Harley Street and London Lauriston Clinic.

“This is a complete digital transformation,” Daya said. “IMVIS makes fully remote eye care possible today while creating the clinical infrastructure for AI-driven diagnostics tomorrow. It’s more than an upgrade—it’s a new standard.”

The timing for this potential breakthrough is ideal, as ophthalmology faces rising pressures from aging populations, limited capacity, and overstretched clinical teams. IMVIS offers a faster, more flexible alternative to the in-person slit lamp exam, enabling documentation, real-time telemedicine, remote collaboration and more efficient patient management. 

By producing accurate 3D video imagery at every visit, IMVIS also eliminates the need for outdated clinical drawings and low-quality 2D images, according to the company. The system’s datasets are well-suited for future artificial intelligence integration and medical education, supporting the development of new training models and diagnostic tools. A fundamental goal of the project has been to make the device affordable enough to be implemented by all eye care providers.

“IMVIS will fundamentally change how we deliver eye care,” Williamson stated. “It will help reduce waiting times, make eye care more accessible, and open the door to scalable, AI-supported clinical decision-making. This is just the beginning. IMVIS will evolve to incorporate AI and reshape how eye care is delivered worldwide.”

Centre for Sight has a track record of global leadership in eye care innovation, from pioneering LASIK laser eye surgery and ICL lens implantation to introducing gold-standard ophthalmic technologies and advanced corneal treatments. The centre receives international referrals and is regularly trusted with cases deemed untreatable elsewhere. Founded in 1996 by Daya, who has performed more than 35,000 cataract procedures and similar number of laser eye procedures, Centre for Sight combines clinical expertise with a patient-first approach.

IMVIS has been developed in partnership with medical innovation catalyst Infinite Medical Ventures, a distinct technology development incubator founded by Williamson and Daya to develop and commercialize innovative ideas from doctors and clinicians.